🇺🇸 FDA
Patent

US 11479540

Nonpeptide somatostatin type 5 receptor agonists and uses thereof

granted A61PA61P3/10

Quick answer

US patent 11479540 (Nonpeptide somatostatin type 5 receptor agonists and uses thereof) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CRINETICS PHARMACEUTICALS, INC.
Grant date
Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
43
CPC classes
A61P, A61P3/10